Jeffrey Simmons

“Elanco's second quarter results demonstrate our momentum and leadership in the attractive, durable animal health industry. I'd like to thank the Global Elanco team for their disciplined execution and once again delivering on our commitments.”

“All right good afternoon I look forward to Bobby and I sharing a lot about our company and I will point also to December 9th we had an investor conference we'll show a few of those highlights as well but really laid out the next three years.”

“Elanco's first quarter represents growing strength, momentum and value. The company's solid first quarter results and raised full year guidance demonstrate continued progress on our priorities of growth, innovation and cash.”

“Elanco's strong third quarter results build on our consistent priorities of growth, innovation, and cash. As highlighted on Slide 4, Elanco continues to deliver, growing 9% organic constant currency in the quarter and outperforming the high end of our guidance for revenue, adjusted EBITDA, and adjusted EPS.”

“Elanco exceeded first quarter guidance for revenue, adjusted EBITDA, and adjusted EPS. Continuing our momentum from the end of 2024, we have delivered a high-quality quarter with 4% organic constant currency revenue growth, evenly driven by price and volume.”